New treatment option for Edentulous Posterior Maxilla
Official title Graftless TSFE Via Self-tapping Implants
ClinicalTrials.gov ID: NCT07424742
What this study is testing
- What it's testing
- This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults aged 18-80 years.
- Patients with edentulous posterior maxilla.
- Residual bone height approximately 4-6 mm.
- Indicated for transcrestal sinus membrane elevation.
- Good general health (ASA I or II).
You likely can't join if
- Severe systemic diseases (ASA III or above).
- Uncontrolled diabetes mellitus.
- Active sinus pathology.
- History of radiotherapy in the head and neck region.
- Heavy smokers (\>10 cigarettes/day).
- Pregnancy or lactation.
See the full eligibility criteria
- Adults aged 18-80 years.
- Patients with edentulous posterior maxilla.
- Residual bone height approximately 4-6 mm.
- Indicated for transcrestal sinus membrane elevation.
- Good general health (ASA I or II).
- Ability to provide written informed consent.
- Willingness to attend follow-up visits.
- Severe systemic diseases (ASA III or above).
- Uncontrolled diabetes mellitus.
- Active sinus pathology.
- History of radiotherapy in the head and neck region.
- Heavy smokers (\>10 cigarettes/day).
- Pregnancy or lactation.
- Untreated periodontal disease. 7\. Poor oral hygiene.
The study team makes the final eligibility decision.
Where it's taking place
- Sanaa, Sanaa Governorate, Yemen
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sanaa, Sanaa Governorate, Yemen. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.